【ChiCTR2400086464】Epidemiology of Acute Sports Injuries in Hong Kong Elite Fencing Athletes
ChiCTR2400086464
正在进行
/
/
/
2024-07-02
/
/
Sports Injury
Epidemiology of Acute Sports Injuries in Hong Kong Elite Fencing Athletes
Epidemiology of Acute Sports Injuries in Hong Kong Elite Fencing Athletes
The objective of this epidemiological study is to investigate the injury mechanisms and determinants of fencing-related injuries at the elite level, filling the knowledge gap in fencing epidemiology. The study will analyze specific factors such as injury types, injury body areas, injury severity, exposure data, incidence rates, relative risks, and injury mechanisms. The findings from the study will contribute to the further development of evidence-based injury prevention strategies to enhance the safety and performance of elite fencers.
队列研究
其它
N/A
Injury data was anonymized before data analysis
N/A
/
40
/
2024-04-01
2025-03-31
/
The inclusion criteria include fencing athletes who are part of the Hong Kong fencing team at the Hong Kong Sports Institute (HKSI) who have received treatment for an injury by in-house physiotherapists at the Sports Medicine Center (SMC) at HKSI.；
请登录查看Any HKSI fencing athletes that were treated for injuries by physiotherapists outside of SMC will be excluded from the study.；
请登录查看Hong Kong Sports Insitute
/
Hong Kong Sports Insitute的其他临床试验
Department of Orthopaedics and traumatology, The Chinese University of Hong Kong的其他临床试验
最新临床资讯
-
一项5年临床安全随访研究启示：#脐带间充质干细胞（#hUC-MSCs）
SCLnow圣释2026-11-11
-
SYNCHRONIZE-CVOT试验达到主要终点，索弗度肽（survodutide）成为全球首个证实心血管安全性的胰高血糖素/GLP-1双受体激动剂
勃林格殷格翰中国2026-11-11
-
医药观澜2026-11-11
-
宜明昂科2026-11-11
-
医学科学院精准医学研究所2026-11-11
-
多肽圈2026-11-11
-
多肽圈2026-11-11
-
求是网2026-11-11
-
干细胞之父2026-11-11
-
和田维药2026-11-11
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-11-12
-
2026-11-12
-
2026-11-12
-
摩熵咨询 20 3
-
摩熵咨询 33 62
-
摩熵咨询 20 3
-
颁布机构：国家卫生健康委办公厅、 2026-11-10
-
颁布机构：国家卫健委（原国家卫计委） 2026-11-10
-
颁布机构：国家药品审评中心（CDE） 2026-10-16
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-11-11
-
2026-11-11
-
2026-11-11
-
摩熵咨询 35 92
-
摩熵咨询 28 74
-
摩熵咨询 34 49
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-07
-
颁布机构：国家市场监督管理总局 2026-11-04